Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Executive Exclusives

Set Alert for Executive Exclusives and Hindsight 20/20

Hindsight 20/20: Elekta's Kevin Brown

Hindsight 20/20 is a Q&A feature where veterans of the medtech industry share career highlights, specific achievements and hurdles they have faced. In this installment, Kevin Brown, global VP of scientific research at radiation therapy specialist Elekta, discusses the challenges of translating scientific ideas into breakthrough technologies that bring value to clinicians and patients. He also addresses his guiding principles for picking winning ideas and his journey bringing to market the world's first integrated high-field MRI and radiotherapy system.

Hindsight 20/20 Innovation

Exec Chat: JNJ's Innovation Partnering Strategy Goes Broad And Beyond 'Pinpoint Intervention'

Medtech's biggest companies are becoming more hands-on in supporting early-stage technologies; their no longer just looking to pick up ready-to-buy assets. Among the most active in this approach is Johnson & Johnson, which has established several vehicles through which it supports and scouts external innovation. Medtech Insight chats with Mirren Mandalia, senior director of new ventures and transactions for medical devices at Johnson & Johnson Innovation, to find out what is driving J&J's technology sourcing strategy and how medtech innovators can work with the diversified health care giant.

Innovation Strategy

Exec Chat: KCI CEO Andrew Eckert Foresees Big Year For Wound-Care Company

Since selling its LifeCell aesthetic and surgical products business to Allergan in early 2017, Acelity has refocused its commercial efforts, and its name, on the KCI wound-care business, with significant investments in medical education, clinical studies and R&D in that sector, as well as the recent acquisition of UK-based Crawford Healthcare.

Exec Chat Innovation

Exec Chat: BD's Head Of Diagnostic Systems On Taking The Long View For Bigger Wins

In the face of BD’s (Becton Dickinson & Co.) ever-broadening portfolio – bulked up by the group's appetite for billion-dollar acquisitions – the Diagnostic Systems unit remains an important, and currently the strongest, contributor to BD's overall growth story. Dave Hickey, worldwide president of BD Diagnostic Systems, spoke to Medtech Insight about the trends that are driving, as well as limiting, the in vitro diagnostics sector, and how BD is addressing those issues to keep the business's top-line buoyant.

In Vitro Diagnostics Business Strategies

Exec Chat: Philips' Connected Care & Health Informatics CEO On IT's Role In Tackling Health-Care Demands

The role of digital technologies in enabling health-care providers to meet rising patient demands and overcome challenges is being increasingly recognized. Yet the health-care sector continues to lag behind other industries in adopting these technologies. CEO of Philips' Connected Care & Health Informatics businesses, Carla Kriwet, tells Medtech Insight what the group has been investing in and where it is innovating to accelerate this digital revolution in health care, and how it is staying ahead of new competition from the ICT sector in this digital health game.

Digital Health Exec Chat

Exec Chat: Breaking Into Asia? Think Long-Term And Engage, Accuron Medtech Chief Advises

For many medtech companies, Asia still holds significant opportunity compared to the persistent slow growth in the more mature US and European markets. But those looking to do business in this region need to plan long term. The biggest mistake is to think you can make a quick buck, says Abel Ang, CEO of Accuron Medtech, Southeast Asia's largest medical device pure-play. The Singapore-based industry veteran shares with Medtech Insight the lessons he learned from his time building businesses for medtech multinationals in APAC and other international markets. He also gives tips from his current experience introducing a disruptive technology to this region.

Asia Pacific Market Access
See All